United Therapeutics (UTHR) Raw Materials (2010 - 2020)
United Therapeutics (UTHR) recorded Raw Materials of $20.1 million in Q1 2020, down 9.9% from $22.3 million a year earlier and down 4.7% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Raw Materials (2010 - 2020) Analysis & Trends
At the end of FY2019, United Therapeutics reported Raw Materials of $21.1 million, down 13.2% from FY2018.
- Annual Raw Materials has a five-year compound annual growth rate of -0.2% (FY2014 to FY2019).
- Across earlier years, Raw Materials came in at $24.3 million in FY2018 (-12.9%), $27.9 million in FY2017 (+9.8%), $25.4 million in FY2016 (+10.0%) and $23.1 million in FY2015 (+8.4%).
- Quarterly Raw Materials has ranged from $19.3 million in Q3 2019 to $29.1 million in Q2 2017 over the past five years.
- On a year-over-year basis, Raw Materials has declined for nine consecutive quarters, with an average decline of 13.5% over the last eight quarters.
- Peak year-over-year performance for Raw Materials in the last five years was growth of 17.3% in Q2 2017, against a decline of 25.8% in Q3 2019 at the low end.
- Per Business Quant, the preceding three quarters came in at $21.1 million (Q4 2019), $19.3 million (Q3 2019) and $20.7 million (Q2 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | United Therapeutics | 25.03 Bn | 15.22 Bn | 733.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 20.10 Mn |
| Dec 31, 2019 | 21.10 Mn |
| Sep 30, 2019 | 19.30 Mn |
| Jun 30, 2019 | 20.70 Mn |
| Mar 31, 2019 | 22.30 Mn |
| Dec 31, 2018 | 24.30 Mn |
| Sep 30, 2018 | 26.00 Mn |
| Jun 30, 2018 | 27.10 Mn |
| Mar 31, 2018 | 24.90 Mn |
| Dec 31, 2017 | 27.90 Mn |
| Sep 30, 2017 | 27.50 Mn |
| Jun 30, 2017 | 29.10 Mn |
| Mar 31, 2017 | 26.50 Mn |
| Dec 31, 2016 | 25.40 Mn |
| Sep 30, 2016 | 24.70 Mn |
| Jun 30, 2016 | 24.80 Mn |
| Mar 31, 2016 | 23.20 Mn |
| Dec 31, 2015 | 23.10 Mn |
| Sep 30, 2015 | 23.32 Mn |
| Jun 30, 2015 | 22.02 Mn |
API Access
United Therapeutics Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();